Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001241271 | SCV001414280 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-12-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002348821 | SCV002619557 | uncertain significance | Cardiovascular phenotype | 2024-11-27 | criteria provided, single submitter | clinical testing | The p.R1241H variant (also known as c.3722G>A), located in coding exon 21 of the FLNC gene, results from a G to A substitution at nucleotide position 3722. The arginine at codon 1241 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002480805 | SCV002793468 | uncertain significance | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26 | 2021-10-21 | criteria provided, single submitter | clinical testing |